In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.

Sofia Perea, Gloria Gonzalez, Annette W. Fothergill, William R. Kirkpatrick, Michael G. Rinaldi, Thomas F. Patterson

Research output: Contribution to journalArticle

185 Scopus citations


The interaction between caspofungin acetate and voriconazole was studied in vitro by using 48 clinical Aspergillus spp. isolates obtained from patients with invasive aspergillosis. MICs were determined by the NCCLS broth microdilution method. Synergy, defined as a fractional inhibitory concentration (FIC) index of <1, was detected in 87.5% of the interactions; an additive effect, defined as an FIC index of 1.0, was observed in 4.2% of the interactions; and a subadditive effect, defined as an FIC index of 1.0 to 2.0, was found in 8.3% of the interactions. No antagonism was observed. Animal models are required to validate the in vivo significance of these in vitro data presented for the combination of caspofungin and voriconazole.

Original languageEnglish (US)
Pages (from-to)3039-3041
Number of pages3
JournalAntimicrobial agents and chemotherapy
Issue number9
Publication statusPublished - Sep 2002


ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this